Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Dow
Cipla
Citi
Cantor Fitzgerald
Deloitte
US Department of Justice
Fuji

Generated: December 14, 2018

DrugPatentWatch Database Preview

Drug Price Trends for METFORMIN HCL ER

« Back to Dashboard

Drug Price Trends for METFORMIN HCL ER

Average Pharmacy Cost for METFORMIN HCL ER

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
METFORMIN HCL ER 750 MG TABLET 65162-0179-10 0.06488 EA 2018-12-12
METFORMIN HCL ER 500 MG TABLET 00185-4416-01 0.03085 EA 2018-11-21
METFORMIN HCL ER 500 MG TABLET 00093-7267-10 0.03085 EA 2018-11-21
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Daiichi Sankyo
Farmers Insurance
Harvard Business School
AstraZeneca
McKinsey
Medtronic
Accenture
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.